A decade of caring for every life
Since 2016, we have transformed from a bold vision into Sri Lanka’s most advanced pharmaceutical facility powered by a skilled team dedicated to improving patient lives.
Built around quality and care
Since its inception, Celogen Lanka has grown into one of Sri Lanka’s leading pharmaceutical groups, delivering high-quality healthcare solutions to hospitals, clinics and patients across the country.
Celogen Lanka represents the Group's finished formulation manufacturing arm, specializing in solid dosage forms. Our state-of-the-art facility is equipped with advanced pharmaceutical machinery, modern quality systems and validated processes designed to meet stringent international manufacturing standards.
Our facility is EU GMP approved and also holds WHO GMP / cGMP approval from NMRA Sri Lanka, reflecting Celogen’s commitment to quality, compliance and patient safety.
Celogen Lanka is also proud to be the first joint venture partner established under the patronage and guidance of the State Pharmaceuticals Manufacturing Corporation of Sri Lanka, supporting the country’s vision of strengthening local pharmaceutical manufacturing to international standards.
We seek to touch lives every day by providing high-quality healthcare products to enrich the lives of our customers, their families, and our stakeholders to support the Earth’s most precious resource – human lives.
Vision & Mission.
Our Vision
To be one of the world’s leading and most admired pharmaceutical companies in the global generics industry by providing international quality products — and consequently make Sri Lanka a self-reliant and competitive global player.
Our Mission
- ✓ To provide the utmost care to patients by manufacturing and delivering high-quality healthcare products at affordable prices.
- ✓ To maintain a continuous focus on innovation, development, research, and technology.
- ✓ To promote niche work opportunities for domestic talents.
Backed by world-class research partnerships
Our R&D capabilities are strengthened through collaborations with established research centres and pharmaceutical partners across India, China and the United States. These partnerships support formulation development, scale-up, technology transfer, analytical development and regulatory readiness for both local and international markets.
Celogen Pharma
EU GMP approved research and development facility supporting formulation development, scale-up and technology transfer.
EU GMP
Kelun Group
Three research institutes located in Chengdu, Suzhou and Tianjin, supporting advanced pharmaceutical research, molecule development and bioequivalence studies.
3 research institutes
KLUS Pharma
Advanced pharmaceutical research partner with regulatory expertise for the United States and international markets.
US Regulatory Expertise
Zydus Research Centre
USFDA & EU GMP approved research and manufacturing partner providing contract research, analytical and manufacturing support.
USFDA · EU GMPBuilding healthier communities and a sustainable future
At Celogen, our responsibility extends beyond manufacturing medicines. We are committed to creating a positive impact through education, healthcare access, community support, disaster response and environmental sustainability.
Education
Supporting the next generation through university internships, academic partnerships, student development initiatives and contributions to schools and educational programmes.
Healthcare
Strengthening access to care through medical supply donations, hospital support programmes and sponsorship of healthcare initiatives that benefit patients and communities.
Community Support
Partnering with charitable organisations, including the Meth Seva Foundation, and supporting orphanages, elderly care homes and vulnerable communities.
Disaster Relief
Responding during natural disasters, epidemics and national emergencies by providing essential medicines, resources and support where they are needed most.
Sustainability
Promoting responsible growth through carbon offsetting practices such as tree planting, conservation, renewable energy initiatives, waste reduction and energy efficiency practices.
Milestones that shaped Celogen
Foundation
Celogen Lanka was established at the Kandy Industrial Park, Pallekele marking the beginning of our journey in advanced pharmaceutical manufacturing.
WHO GMP/NMRA
Celogen Lanka received GMP approval from NMRA Sri Lanka under WHO GMP standards, reinforcing our commitment to quality, compliance and patient safety.
EU GMP
Celogen Lanka became the first pharmaceutical manufacturing site in Sri Lanka to receive EU GMP approval, setting a new benchmark for the local industry.
Growth & Scale
Celogen expanded into a portfolio of 650+ products, supported by a skilled team of more than 500 professionals.